pentobarbital will lessen the extent or outcome of larotrectinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism.pentobarbital will reduce the level or influence of mavacamten by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.pentobarbital will reduce the extent or impact of fosaprepitant by affecting hepatic/inte